Arabic Arabic English English French French German German
dark

Erythropoietin treatments may increase hip fracture risk in patients with kidney failure

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How accurate are virtual assessments of cognitive function?

Next Post

Do bacteria in the mouth affect risk of developing rheumatoid arthritis?

Related Posts
Total
0
Share